Home
- Questions About Raises, Shuttle Fees Top Administrators Forum
A UAMS Update article about Meet Your Administrator”
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Doughnut Sale to Help UAMS Psychiatry Youth Program
A UAMS Update article about a bake sale
- Call-in Announcements, Forums Will Give Employees More Information
A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center
- IT Help Desk 400,000th Call Sweepstakes
IT Help Desk 400,000th Call Sweepstates
- The UAMS Help Desk Today - Ten Years Later
The UAMS Help Desk Today - Ten Years Later
- Free Tickets for UAMS Nights at Ray Winder Field
A UAMS Update article about UAMS Night with the Travelers
- ARIA Training Sessions May 19 - June 27 at UAMS
A UAMS Update article about May 19 - June 27 training sessions
- Human Research Forum Is May 21
A UAMS Update article about human research Q & A
- Accolades, May 2003
Accolades to UAMS faculty and staff
- GCRC Deadline Changed to July 1 for Grant Proposals
A UAMS Update article about GCRC pilot grants
- History of the Help Desk
- Watch, Look & Listen: Preview of New UAMS Public Service Campaign
- Forum to Discuss Impact of HIPAA on Research
Update article about HIPAA and research at UAMS
- Human Research Q and A Forum June 27
A UAMS Update article about the human research forum
- Emailed Version of UAMS Notice of Privacy Practices
UAMS Notice of Privacy Practices
- Free UAF Symposium Aug. 14-15 on Evolution of Human Diet
A UAMS Update article about a diet symposium at UAF
- Tom Butler is Arkansas Administrator of the Year
Tom Butler of UAMS Is Arkansas Administrator of the Year
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
- Kids First in Fort Smith Celebrated Fourth in Style
Kids First in Fort Smith Celebrated Fourth in Style
- Class of 1948 Dedicates Endowment to Excellence in Education
Class of 1948 Dedicates Endowment to Excellence in Education
- Pharmacy Professor Elected to American College of Clinical Pharmacy
Pharmacy Professor Elected to American College of Clinical Pharmacy
- Pharmaceutical Scientists, Graduate Students Meet at UAMS
Pharmaceutical Scientists, Graduate Students Meet at UAMS
- Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
- New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
- Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™
UAMS, KATV Launch Get Healthy Arkansas™
- Men to Get off the Sidelines and into the Race in 5K to Raise Money to Fight Prostate Cancer
Men to Get off the Sidelines and into the Race in 5K to Raise Money to Fight Prostate Cancer
- Students Spend Summer as Partners in Research at UAMS
Students Spend Summer as Partners in Research at UAMS
- Students Spend Summer as Partners in Research at UAMS
Students Spend Summer as Partners in Research at UAMS
- Students Spend Summer as Partners in Research at UAMS
Students Spend Summer as Partners in Research at UAMS
- Students Spend Summer as Partners in Research at UAMS
Students Spend Summer as Partners in Research at UAMS
- UAMS Advocates Join BMW Ultimate Drive™ to Support Komen Foundation
: A UAMS Today article about participation in the BMW Ultimate Drive™, a promotion for the Susan G. Komen Breast Cancer Foundation
- UAMS Advocates Join BMW Ultimate Drive™ to Support Komen Foundation
: A UAMS Today article about participation in the BMW Ultimate Drive™, a promotion for the Susan G. Komen Breast Cancer Foundation
- UAMS Advocates Join BMW Ultimate Drive™ to Support Komen Foundation
: A UAMS Today article about participation in the BMW Ultimate Drive™, a promotion for the Susan G. Komen Breast Cancer Foundation
- UAMS Advocates Join BMW Ultimate Drive™ to Support Komen Foundation
: A UAMS Today article about participation in the BMW Ultimate Drive™, a promotion for the Susan G. Komen Breast Cancer Foundation
- Photo Album: Thomas Kieber-Emmons, Ph.D., Is First Josetta Edwards Wilkins, Ed.D., Chair in Breast Cancer Research
Photo Album: Thomas Kieber-Emmons, Ph.D., Is First Josetta Edwards Wilkins, Ed.D., Chair in Breast Cancer Research
- Photo Album: Thomas Kieber-Emmons, Ph.D., Is First Josetta Edwards Wilkins, Ed.D., Chair in Breast Cancer Research
Photo Album: Thomas Kieber-Emmons, Ph.D., Is First Josetta Edwards Wilkins, Ed.D., Chair in Breast Cancer Research
- Photo Album: Thomas Kieber-Emmons, Ph.D., Is First Josetta Edwards Wilkins, Ed.D., Chair in Breast Cancer Research
Photo Album: Thomas Kieber-Emmons, Ph.D., Is First Josetta Edwards Wilkins, Ed.D., Chair in Breast Cancer Research
- Research by Thomas Kieber-Emmons Could Lead to Cancer Vaccines
Research by Thomas Kieber-Emmons Could Lead to Cancer Vaccines
- Research by Thomas Kieber-Emmons Could Lead to Cancer Vaccines
Research by Thomas Kieber-Emmons Could Lead to Cancer Vaccines
- Research by Thomas Kieber-Emmons Could Lead to Cancer Vaccines
Research by Thomas Kieber-Emmons Could Lead to Cancer Vaccines
- UAMS Cancer Researcher Obtains $1.5 Million for Study of Bone Cancer
SEPT. 5, 2003 | Ralph D. Sanderson, Ph.D., of the Arkansas Cancer Research Center (ACRC), part of the University of Arkansas for Medical Sciences (UAMS), has obtained a $1.5 million grant from the National Cancer Institute for his groundbreaking work on the growth of tumor cells in bone.
- UAMS Cancer Researcher Obtains $1.5 Million for Study of Bone Cancer
SEPT. 5, 2003 | Ralph D. Sanderson, Ph.D., of the Arkansas Cancer Research Center (ACRC), part of the University of Arkansas for Medical Sciences (UAMS), has obtained a $1.5 million grant from the National Cancer Institute for his groundbreaking work on the growth of tumor cells in bone.
- “Cure Breast Cancer” Tag Supports Research at UAMS
SEPT. 5, 2003 | The long-awaited Arkansas “Cure Breast Cancer” car license plates are now available – and proceeds go to cancer research at the University of Arkansas for Medical Sciences (UAMS) and to the Susan G. Komen Breast Cancer Foundation.
- “Cure Breast Cancer” Tag Supports Research at UAMS
SEPT. 5, 2003 | The long-awaited Arkansas “Cure Breast Cancer” car license plates are now available – and proceeds go to cancer research at the University of Arkansas for Medical Sciences (UAMS) and to the Susan G. Komen Breast Cancer Foundation.
- “Cure Breast Cancer” Tag Supports Research at UAMS
SEPT. 5, 2003 | The long-awaited Arkansas “Cure Breast Cancer” car license plates are now available – and proceeds go to cancer research at the University of Arkansas for Medical Sciences (UAMS) and to the Susan G. Komen Breast Cancer Foundation.
- UAMS Laser Scientist “Tags” Gold Particle Targets to Kill Breast Cancer Cells
SEPT. 10, 2003 | Vladimir P. Zharov, Ph.D., a biomedical laser research pioneer at the University of Arkansas for Medical Sciences (UAMS), has won a prestigious grant from the U.S. Department of Defense to investigate a new way to kill breast cancer cells using laser radiation and gold nanoparticles.
- UAMS Laser Scientist “Tags” Gold Particle Targets to Kill Breast Cancer Cells
SEPT. 10, 2003 | Vladimir P. Zharov, Ph.D., a biomedical laser research pioneer at the University of Arkansas for Medical Sciences (UAMS), has won a prestigious grant from the U.S. Department of Defense to investigate a new way to kill breast cancer cells using laser radiation and gold nanoparticles.
- UAMS Laser Scientist “Tags” Gold Particle Targets to Kill Breast Cancer Cells
SEPT. 10, 2003 | Vladimir P. Zharov, Ph.D., a biomedical laser research pioneer at the University of Arkansas for Medical Sciences (UAMS), has won a prestigious grant from the U.S. Department of Defense to investigate a new way to kill breast cancer cells using laser radiation and gold nanoparticles.
- Laser Could Open Up World
- Laser Could Open Up World
- UAMS Surgeon to Give Breast Cancer Update March 8 at Air Force Base
- UAMS Surgeon to Give Breast Cancer Update March 8 at Air Force Base
- "Imus in the Morning" Praises Two UAMS Doctors
UAMS doctors James Suen and Gazi Yasargil cited by Don Imus on national radio program
- "Imus in the Morning" Praises Two UAMS Doctors
UAMS doctors James Suen and Gazi Yasargil cited by Don Imus on national radio program
- "Imus in the Morning" Praises Two UAMS Doctors
UAMS doctors James Suen and Gazi Yasargil cited by Don Imus on national radio program
- "Imus in the Morning" Praises Two UAMS Doctors
UAMS doctors James Suen and Gazi Yasargil cited by Don Imus on national radio program
- ACRC Auxiliary’s Annual Cooks Tour Raises More than $50,000 for Family Home; Ronda Henry Tillman, M.D., Is Honored with Special Award
MAY 3, 2004 | It was the perfect way to spend a Sunday afternoon – enjoying delicious food prepared by some of Little Rock’s finest chefs and touring four beautiful homes in the Sologne area of Chenal Valley as the Arkansas Cancer Research Center (ACRC) Auxiliary held its annual Cooks Tour fund-raiser, April 25.
- ACRC Auxiliary’s Annual Cooks Tour Raises More than $50,000 for Family Home; Ronda Henry Tillman, M.D., Is Honored with Special Award
MAY 3, 2004 | It was the perfect way to spend a Sunday afternoon – enjoying delicious food prepared by some of Little Rock’s finest chefs and touring four beautiful homes in the Sologne area of Chenal Valley as the Arkansas Cancer Research Center (ACRC) Auxiliary held its annual Cooks Tour fund-raiser, April 25.
- ACRC Auxiliary’s Annual Cooks Tour Raises More than $50,000 for Family Home; Ronda Henry Tillman, M.D., Is Honored with Special Award
MAY 3, 2004 | It was the perfect way to spend a Sunday afternoon – enjoying delicious food prepared by some of Little Rock’s finest chefs and touring four beautiful homes in the Sologne area of Chenal Valley as the Arkansas Cancer Research Center (ACRC) Auxiliary held its annual Cooks Tour fund-raiser, April 25.
- ACRC Auxiliary’s Annual Cooks Tour Raises More than $50,000 for Family Home; Ronda Henry Tillman, M.D., Is Honored with Special Award
MAY 3, 2004 | It was the perfect way to spend a Sunday afternoon – enjoying delicious food prepared by some of Little Rock’s finest chefs and touring four beautiful homes in the Sologne area of Chenal Valley as the Arkansas Cancer Research Center (ACRC) Auxiliary held its annual Cooks Tour fund-raiser, April 25.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- UAMS Receives $541,495 in National Settlement Over Taxol Cost
JUNE 14, 2004 | Cancer programs at the University of Arkansas for Medical Sciences will receive $541,495 as part of a national settlement with Bristol-Myers Squibb, which manufacturers the cancer-fighting drug Taxol.
- Sturgis Trust Gives $500,000 for Rural Cancer Screenings
Sturgis Trust offers $500,000 grant for cancer screenings in rural Arkansas
- Sturgis Trust Gives $500,000 for Rural Cancer Screenings
Sturgis Trust offers $500,000 grant for cancer screenings in rural Arkansas
- "Annals of Surgery" Reports UAMS Breast Biopsy Technique
ANNALS OF SURGERY reports new technique developed at UAMS Medical Center for breast cancer biopsy
- "Annals of Surgery" Reports UAMS Breast Biopsy Technique
ANNALS OF SURGERY reports new technique developed at UAMS Medical Center for breast cancer biopsy
- "Annals of Surgery" Reports UAMS Breast Biopsy Technique
ANNALS OF SURGERY reports new technique developed at UAMS Medical Center for breast cancer biopsy
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- UAMS Researcher Wins International Award for Ovarian Cancer Research
JULY 9, 2004 | O’Brien, Ph.D., professor in the Department of Obstetrics and Gynecology in the University of Arkansas for Medical Sciences (UAMS) College of Medicine and director of UAMS Arkansas BioVentures, recently won the coveted Abbott Award in recognition of a lifetime of work in the area of ovarian cancer research.
- Cancer Care at ACRC of UAMS Ranked High by U.S. News & World Report
Cancer Care at UAMS ranked high with USN&WR
- Cancer Care at ACRC of UAMS Ranked High by U.S. News & World Report
Cancer Care at UAMS ranked high with USN&WR
- Cancer Care at ACRC of UAMS Ranked High by U.S. News & World Report
Cancer Care at UAMS ranked high with USN&WR
- UAMS Promises Cancer Treatment with Loving Care, Devotion
UAMS physicians and leaders stress patient care with caring and compassion
- UAMS Promises Cancer Treatment with Loving Care, Devotion
UAMS physicians and leaders stress patient care with caring and compassion
- UAMS Promises Cancer Treatment with Loving Care, Devotion
UAMS physicians and leaders stress patient care with caring and compassion
- UAMS to Create Myeloma Institute
UAMS announces Myeloma Institute for Research and Therapy
- UAMS to Create Myeloma Institute
UAMS announces Myeloma Institute for Research and Therapy
- UAMS to Create Myeloma Institute
UAMS announces Myeloma Institute for Research and Therapy
- Here’s to Your Health: Prostate Cancer
HTYH radio program series about: Prostate Cancer
- Here’s to Your Health: Prostate Cancer
HTYH radio program series about: Prostate Cancer
- Here’s to Your Health: Prostate Cancer
HTYH radio program series about: Prostate Cancer
- Here’s to Your Health: Prostate Cancer
HTYH radio program series about: Prostate Cancer
- Lou Rawls To Be Entertainer at ACRC Gala
R&B singer Lou Rawls will be featured entertainer at the ACRC annual gala.
- Lou Rawls To Be Entertainer at ACRC Gala
R&B singer Lou Rawls will be featured entertainer at the ACRC annual gala.
- Cancer Director to Speak at Summit
Suen to speak at Summit; statewide cancer plan to be reviewed
- Cancer Director to Speak at Summit
Suen to speak at Summit; statewide cancer plan to be reviewed
- Cancer Director to Speak at Summit
Suen to speak at Summit; statewide cancer plan to be reviewed
- UAMS Surgeon to Appear on KATV/7
Dr. Henry-Tillman will discuss efforts to increase cancer screenings.
- UAMS Surgeon to Appear on KATV/7
Dr. Henry-Tillman will discuss efforts to increase cancer screenings.
- UAMS Surgeon to Appear on KATV/7
Dr. Henry-Tillman will discuss efforts to increase cancer screenings.
- Redbook Recognizes UAMS Breast Cancer Specialists
Two breast cancer specialists at Arkansas Cancer Research Center at UAMS recently appeared in a list of “Top Breast Doctors in America” in the October issue of the popular women’s magazine, Redbook.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Gray’s Anomaly: A Source of Empowerment
Feb. 8, 2012 | “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed.
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Code Moo Now Open
Code Moo Now Open
- Code Moo Now Open
Code Moo Now Open
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
|
May 18, 2004 | Dr. Bart Barlogie’s career has taken him to many far-flung locations but always in the same direction. Finding a cure for multiple myeloma has been Barlogie’s prime motivation for almost 30 years, and it was with that goal in mind that the International Myeloma Foundation honored him with the Robert A. Kyle Lifetime Achievement Award May 8 at a special event held at the Peabody Little Rock.
The director of the Myeloma Institute for Research and Therapy at UAMS’ Arkansas Cancer Research Center, Barlogie was recognized by numerous colleagues and officials over the course of the evening. Among the highlights was an announcement by Chancellor I. Dodd Wilson that UAMS planned to raise funds to invest a chair in myeloma research in honor of Barlogie and his efforts toward curing the rare but deadly form of cancer. Dr. Ernest Ferris, chairman of UAMS’ Department of Radiology, called Barlogie “a patient’s best friend” and presented him with a $40,000 donation to the Myeloma Institute’s Patient Awareness Fund.
A video presentation by Gov. Mike Huckabee touched on Barlogie’s commitment not only to his work but to his patients. Donna Lambert of St. Louis, a patient of Barlogie’s, echoed those sentiments in a short speech while Dr. Emil Freireich of the M.D. Anderson Cancer Center in Houston complimented his former employee for his dedication to “learning about the disease from patients, not mice.”
Dr. Brian Durie and Susie Novis of the International Myeloma Foundation commended Barlogie for the passion displayed in his work while Dr. Robert Kyle of the Mayo Clinic, for whom the award was named, complimented him for his ability to recognize his patients’ needs and put them before his own.
John Shaughnessy, director of the Myeloma Institute’s Lambert Laboratory of Myeloma Genetics, characterized Barlogie as a perfectionist. “Since 1989, Bart and his team of physicians have had over 20,000 clinic visits from patients with myeloma. I think Bart himself has seen nearly a third of these patients. His patients always wonder why they have to wait so long to see him. It’s because every patient gets the best Bart has to offer and that takes time!” said Shaughnessy, who noted that Barlogie’s labors at UAMS have more than doubled the survival rate of myeloma patients.
Barlogie, upon receiving the award from Kyle, thanked his comrades as well as his patients, asking those in attendance to stand and be recognized for their contributions to his pursuit of a cure for myeloma. “I was born on May 10, 1944, in the ruins of World War II. My mother and my stepfather taught me that you had to work hard to build something from the ashes. Mother always told me that what I could get in my head no one could take away,” said a visibly overwhelmed Barlogie.
“In medicine and the scientific profession, we stand on each others’ shoulders. We remember that we are not creating things out of nothing but out of a succession of scientists and clinicians whose work allows us to pursue our vision. What we try and accomplish is about patients. A diagnosis of multiple myeloma is worse than many things … it’s really very difficult … different patients deal with it differently. It’s not sufficient to just double the survival rate. We have to keep the momentum and energy and learn to deal with failure. I was evidently given tough genes and work in an environment where we don’t give up.” |